Most of the bio companies ARK invests in are US-based, and we do not believe tariffs will impact them. In fact, we view recent tariff policies as a tailwind accelerating the growth of the US biotech footprint. Research Analyst Nemo Marjanovic, PhD discusses our biotech strategy in this askARK.
Similar Posts
‘You’re dangerous’: Trump allies turn on each other
President Donald Trump’s public falling out with Tesla and SpaceX CEO Elon Musk is now prompting…
What happens when we stop reading? | The Gray Area
What happens when we read less? What does that do to our ability to understand complex…
View from the Hill: Albanese supports US bombing, reluctantly
For Australia’s there is one big difference: there is no thought of involving Australian defence forces,…
Megyn Kelly spoke out about Roger Ailes’ sexual harassment at Fox News too little, too late
For a transcript of an episode of Hysteria, please email [email protected]. Political commentator and comedy writer…
Iranian and Israeli official channels broadcast fake images of the conflict • FRANCE 24 English
Fake images of the conflict are not only going viral on social media, but on television…
War on Iran: Trump holds off on attacking Iran
US President Donald Trump says he postponed a planned attack on Iran at Gulf countries’ request…
